Jones Financial Companies
TERN

Jones Financial Companies’s Terns Pharmaceuticals TERN Stock Holding History

Jones Financial Companies’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$665K Buy
+12,567
New +$516K ﹤0.01% 1903

Other funds holding TERN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Jones Financial Companies's TERN Position: Q1 2026 in Review

Jones Financial Companies opened a new position in Terns Pharmaceuticals (TERN) in Q1 2026: 12,567 shares worth $665K. The stake represents ﹤0.01% of the portfolio and ranks #1903 among its holdings.

317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Jones Financial Companies held 12,567 shares of Terns Pharmaceuticals worth $665K as of Q1 2026.
  • Terns Pharmaceuticals was a new Jones Financial Companies position in Q1 2026.
  • Terns Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #1903 holding.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.